The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Contraceptives Market Research Report 2024

Global Contraceptives Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1386932

No of Pages : 104

Ask Your Query

Synopsis
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods.

These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

The global Contraceptives market was valued at US$ 1911.9 million in 2023 and is anticipated to reach US$ 2277.4 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives.

Report Scope

The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.

By Company

  • Bayer AG
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc
  • Actavis, Inc.
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
  • Sine
  • Reckitt
  • AbbVie
  • Church & Dwight
  • The Cooper Companies
  • TherapeuticsMD
  • Afaxys
  • Mithra Pharmaceuticals

Segment by Type

  • Pills
  • Injectable
  • Condoms
  • Vaginal Rings
  • IUDs
  • Subdermal Implants
  • Others

Segment by End User

  • 15–24 years
  • 25–34 years
  • 35–44 years
  • Above 44 years

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Contraceptives Market Overview
1.1 Product Overview and Scope of Contraceptives
1.2 Contraceptives Segment by Type
1.2.1 Global Contraceptives Market Value Comparison by Type (2024-2030)
1.2.2 Pills
1.2.3 Injectable
1.2.4 Condoms
1.2.5 Vaginal Rings
1.2.6 IUDs
1.2.7 Subdermal Implants
1.2.8 Others
1.3 Contraceptives Segment by End User
1.3.1 Global Contraceptives Market Value by End User: (2024-2030)
1.3.2 15–24 years
1.3.3 25–34 years
1.3.4 35–44 years
1.3.5 Above 44 years
1.4 Global Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Contraceptives Revenue 2019-2030
1.4.2 Global Contraceptives Sales 2019-2030
1.4.3 Global Contraceptives Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Contraceptives Market Competition by Manufacturers
2.1 Global Contraceptives Sales Market Share by Manufacturers (2019-2024)
2.2 Global Contraceptives Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Contraceptives Average Price by Manufacturers (2019-2024)
2.4 Global Contraceptives Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contraceptives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contraceptives, Product Type & Application
2.7 Contraceptives Market Competitive Situation and Trends
2.7.1 Contraceptives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Contraceptives Players Market Share by Revenue
2.7.3 Global Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Contraceptives Retrospective Market Scenario by Region
3.1 Global Contraceptives Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Contraceptives Global Contraceptives Sales by Region: 2019-2030
3.2.1 Global Contraceptives Sales by Region: 2019-2024
3.2.2 Global Contraceptives Sales by Region: 2025-2030
3.3 Global Contraceptives Global Contraceptives Revenue by Region: 2019-2030
3.3.1 Global Contraceptives Revenue by Region: 2019-2024
3.3.2 Global Contraceptives Revenue by Region: 2025-2030
3.4 North America Contraceptives Market Facts & Figures by Country
3.4.1 North America Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Contraceptives Sales by Country (2019-2030)
3.4.3 North America Contraceptives Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contraceptives Market Facts & Figures by Country
3.5.1 Europe Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Contraceptives Sales by Country (2019-2030)
3.5.3 Europe Contraceptives Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptives Market Facts & Figures by Country
3.6.1 Asia Pacific Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Contraceptives Sales by Country (2019-2030)
3.6.3 Asia Pacific Contraceptives Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Contraceptives Sales by Country (2019-2030)
3.7.3 Latin America Contraceptives Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Contraceptives Sales by Country (2019-2030)
3.8.3 Middle East and Africa Contraceptives Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Contraceptives Sales by Type (2019-2030)
4.1.1 Global Contraceptives Sales by Type (2019-2024)
4.1.2 Global Contraceptives Sales by Type (2025-2030)
4.1.3 Global Contraceptives Sales Market Share by Type (2019-2030)
4.2 Global Contraceptives Revenue by Type (2019-2030)
4.2.1 Global Contraceptives Revenue by Type (2019-2024)
4.2.2 Global Contraceptives Revenue by Type (2025-2030)
4.2.3 Global Contraceptives Revenue Market Share by Type (2019-2030)
4.3 Global Contraceptives Price by Type (2019-2030)
5 Segment by End User
5.1 Global Contraceptives Sales by End User (2019-2030)
5.1.1 Global Contraceptives Sales by End User (2019-2024)
5.1.2 Global Contraceptives Sales by End User (2025-2030)
5.1.3 Global Contraceptives Sales Market Share by End User (2019-2030)
5.2 Global Contraceptives Revenue by End User (2019-2030)
5.2.1 Global Contraceptives Revenue by End User (2019-2024)
5.2.2 Global Contraceptives Revenue by End User (2025-2030)
5.2.3 Global Contraceptives Revenue Market Share by End User (2019-2030)
5.3 Global Contraceptives Price by End User (2019-2030)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer AG Contraceptives Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Corporation Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer, Inc Contraceptives Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.4 Merck & Co., Inc
6.4.1 Merck & Co., Inc Corporation Information
6.4.2 Merck & Co., Inc Description and Business Overview
6.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co., Inc Contraceptives Product Portfolio
6.4.5 Merck & Co., Inc Recent Developments/Updates
6.5 Actavis, Inc.
6.5.1 Actavis, Inc. Corporation Information
6.5.2 Actavis, Inc. Description and Business Overview
6.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actavis, Inc. Contraceptives Product Portfolio
6.5.5 Actavis, Inc. Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Contraceptives Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Gedeon Richter
6.6.1 Gedeon Richter Corporation Information
6.6.2 Gedeon Richter Description and Business Overview
6.6.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gedeon Richter Contraceptives Product Portfolio
6.7.5 Gedeon Richter Recent Developments/Updates
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Corporation Information
6.8.2 Novo Nordisk A/S Description and Business Overview
6.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments/Updates
6.9 ZiZhu
6.9.1 ZiZhu Corporation Information
6.9.2 ZiZhu Description and Business Overview
6.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZiZhu Contraceptives Product Portfolio
6.9.5 ZiZhu Recent Developments/Updates
6.10 Baijingyu
6.10.1 Baijingyu Corporation Information
6.10.2 Baijingyu Description and Business Overview
6.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baijingyu Contraceptives Product Portfolio
6.10.5 Baijingyu Recent Developments/Updates
6.11 Huazhong
6.11.1 Huazhong Corporation Information
6.11.2 Huazhong Contraceptives Description and Business Overview
6.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huazhong Contraceptives Product Portfolio
6.11.5 Huazhong Recent Developments/Updates
6.12 Sine
6.12.1 Sine Corporation Information
6.12.2 Sine Contraceptives Description and Business Overview
6.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sine Contraceptives Product Portfolio
6.12.5 Sine Recent Developments/Updates
6.13 Reckitt
6.13.1 Reckitt Corporation Information
6.13.2 Reckitt Contraceptives Description and Business Overview
6.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Reckitt Contraceptives Product Portfolio
6.13.5 Reckitt Recent Developments/Updates
6.14 AbbVie
6.14.1 AbbVie Corporation Information
6.14.2 AbbVie Contraceptives Description and Business Overview
6.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AbbVie Contraceptives Product Portfolio
6.14.5 AbbVie Recent Developments/Updates
6.15 Church & Dwight
6.15.1 Church & Dwight Corporation Information
6.15.2 Church & Dwight Contraceptives Description and Business Overview
6.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Church & Dwight Contraceptives Product Portfolio
6.15.5 Church & Dwight Recent Developments/Updates
6.16 The Cooper Companies
6.16.1 The Cooper Companies Corporation Information
6.16.2 The Cooper Companies Contraceptives Description and Business Overview
6.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.16.4 The Cooper Companies Contraceptives Product Portfolio
6.16.5 The Cooper Companies Recent Developments/Updates
6.17 TherapeuticsMD
6.17.1 TherapeuticsMD Corporation Information
6.17.2 TherapeuticsMD Contraceptives Description and Business Overview
6.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.17.4 TherapeuticsMD Contraceptives Product Portfolio
6.17.5 TherapeuticsMD Recent Developments/Updates
6.18 Afaxys
6.18.1 Afaxys Corporation Information
6.18.2 Afaxys Contraceptives Description and Business Overview
6.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Afaxys Contraceptives Product Portfolio
6.18.5 Afaxys Recent Developments/Updates
6.19 Mithra Pharmaceuticals
6.19.1 Mithra Pharmaceuticals Corporation Information
6.19.2 Mithra Pharmaceuticals Contraceptives Description and Business Overview
6.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
6.19.5 Mithra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptives Industry Chain Analysis
7.2 Contraceptives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptives Production Mode & Process
7.4 Contraceptives Sales and Marketing
7.4.1 Contraceptives Sales Channels
7.4.2 Contraceptives Distributors
7.5 Contraceptives Customers
8 Contraceptives Market Dynamics
8.1 Contraceptives Industry Trends
8.2 Contraceptives Market Drivers
8.3 Contraceptives Market Challenges
8.4 Contraceptives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock